Sunshine Biopharma Inc (SBFM) — Financial Flexibility Index
Sunshine Biopharma Inc (SBFM) has a Financial Flexibility Index of -0.12x as of March 2026. Free cash flow of $-845.76K (operating CF $-1.62 Million minus capex $770.24K) represents 0% of total liabilities ($7.04 Million). Check Sunshine Biopharma Inc (SBFM) strategic asset index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Sunshine Biopharma Inc Financial Flexibility Index (2007–2025)
Historical Financial Flexibility Index trend for Sunshine Biopharma Inc across 19 annual periods. See SBFM net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Sunshine Biopharma Inc (2007–2025)
Year-by-year free cash flow to debt coverage for Sunshine Biopharma Inc. For the full company profile including market capitalisation, see Sunshine Biopharma Inc market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.73x | $-5.16 Million | $-5.33 Million | $7.04 Million | ▲ +49.4% |
| 2024 | -1.45x | $-10.21 Million | $-12.53 Million | $7.06 Million | ▼ -11.2% |
| 2023 | -1.30x | $-7.99 Million | $-8.78 Million | $6.14 Million | ▼ -108.4% |
| 2022 | -0.62x | $-4.94 Million | $-5.25 Million | $7.92 Million | ▲ +32.0% |
| 2021 | -0.92x | $-1.83 Million | $-1.83 Million | $1.99 Million | ▼ -180.1% |
| 2020 | -0.33x | $-656.11K | $-657.30K | $2.00 Million | ▲ +44.8% |
| 2019 | -0.59x | $-494.94K | $-495.80K | $833.53K | ▼ -44.5% |
| 2018 | -0.41x | $-493.96K | $-512.81K | $1.20 Million | ▲ +36.8% |
| 2017 | -0.65x | $-539.80K | $-543.52K | $830.85K | ▲ +42.7% |
| 2016 | -1.13x | $-310.74K | $-314.18K | $274.10K | ▼ -490.1% |
| 2015 | -0.19x | $-244.04K | $-867.64K | $1.27 Million | ▲ +80.9% |
| 2014 | -1.01x | $-533.80K | $-538.60K | $531.00K | ▲ +93.0% |
| 2013 | -14.37x | $-559.61K | $-564.40K | $38.95K | ▼ -135.3% |
| 2012 | -6.11x | $-393.05K | $-393.05K | $64.37K | ▲ +92.9% |
| 2011 | -86.58x | $-297.30K | $-297.30K | $3.43K | ▼ -183.4% |
| 2010 | -30.54x | $-348.32K | $-348.32K | $11.40K | ▼ -4175.9% |
| 2009 | -0.71x | $-10.22K | $-10.22K | $14.31K | ▲ +29.5% |
| 2008 | -1.01x | $-23.03K | $-23.03K | $22.74K | ▲ +51.3% |
| 2007 | -2.08x | $-3.12K | $-3.12K | $1.50K | — |